Form 4: Shanghai Science & Technology Venture Capital Sells Shares in ACM Research

Shanghai Science & Technology Venture Capital (Group) Co., Ltd. sold shares of ACM Research (ACMR) between October 4 and October 8, 2024, reducing its direct holdings.

Summary

• Shanghai Science & Technology Venture Capital (Group) Co., Ltd. (SSTVC) and Shanghai Pudong Science & Technology Investment Group Co., Ltd. (SPTIG) jointly filed a Form 4 indicating changes in beneficial ownership of ACM Research, Inc. (ACMR) securities.
• SSTVC executed multiple sales of Class A Common Stock between October 4 and October 8, 2024.
• The sales were conducted under a Rule 10b5-1 plan adopted on June 12, 2024.
• On October 4, 2024, 570,735 shares were sold at a weighted average price of $21.52, and 129,265 shares were sold at a weighted average price of $20.94.
• On October 7, 2024, sales included 100,514 shares at $25.36, 1,481 shares at $25.02, and 173,005 shares at $23.32.
• On October 8, 2024, 90,396 shares were sold at $21.13.
• Following these transactions, SSTVC directly owns 2,338,510 shares and indirectly owns 3,358,728 shares through SPTIG.
• SSTVC holds a 46% equity interest in SPTIG.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports share sales under a pre-existing plan, without indicating any fundamental issues with the company.

Negatives

• Shanghai Science & Technology Venture Capital (Group) Co., Ltd. reduced its direct holdings in ACM Research through a series of sales.

Industry Context

Share sales by major shareholders can sometimes create short-term price volatility but are not uncommon, especially when executed under pre-arranged trading plans.

Stakeholder Impact

• The share sales may cause short-term volatility for shareholders.
• The sales do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates